Pediatrix Q4 net income $30M, Adjusted EPS $0.51, revenue up to $502M

Pediatrix Medical Group, Inc.

2024-FY EPS reported -$1.19 revenue$2,012,919,000

GAAP EPS $0.36 (vs $1.50 loss Q4 2023); Adjusted EPS $0.51 (vs $0.32).
Net revenue $502M, up from $496M; same-unit revenue grew 8.7%.
Adjusted EBITDA $68.7M (vs $50.8M); portfolio restructuring completed by Dec 31, 2024.
Preliminary 2025 Adjusted EBITDA guidance $215M-$235M.
Cash from operations $134.8M; total debt $616M; no revolver borrowings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.